Dressing Cells in an “Antifreeze Coat”: Chlorogenic Acid Can Improve the Cryosurvival Rate of Germline Stem Cells
Release time:
2026-09-18
Recently, a research team from the University of Tehran and other institutions in Iran confirmed in animal experiments that adding chlorogenic acid, a natural plant polyphenol, to the cryoprotectant can significantly improve the post-thaw survival and differentiation capacity of germline stem cells after cryopreservation. This achievement provides a new experimental basis for fertility preservation before radiotherapy and chemotherapy in young children with cancer, and the related mechanistic research also opens new avenues for upgrading the formulations of cryopreservation solutions used in assisted reproduction.

The “Freezing Challenge” of Fertility Preservation
In pediatric cancer treatment, radiotherapy and chemotherapy save lives while often causing irreversible damage to germ cells, leading to loss of fertility in adulthood. Currently, cryopreservation of germline stem cells is an important means of preserving fertility, but traditional cryoprotectants rely on dimethyl sulfoxide (DMSO) or glycerol. During cryogenic freezing and rewarming, ice crystal formation and abrupt osmotic changes trigger severe oxidative stress, leading to cell membrane rupture or initiation of apoptosis, which severely affects cell survival and engraftment after thawing.
Chlorogenic Acid Activates an “Antioxidant Switch”
To find safer protective agents, the research team used a testicular torsion-induced azoospermia mouse model to mimic tissue damage caused by ischemia-reperfusion. They divided donor germline stem cells into fresh transplantation, chlorogenic acid-containing cryopreservation, basal cryoprotectant cryopreservation, and blank control groups.
At a concentration of 100 μM, after eight weeks of in vivo engraftment assessment, the group supplemented with chlorogenic acid showed higher SALL4 and PAX7 protein expression levels by flow cytometry, indicating that the stem cells successfully engrafted into the seminiferous tubule epithelium and maintained stemness characteristics. Molecular mechanism analysis revealed that chlorogenic acid mainly acts by activating the PI3K/Akt/Nrf2 signaling pathway, which regulates cell survival and endogenous antioxidant defense. The experiments also observed downregulation of the pro-apoptotic gene Bax and upregulation of the anti-apoptotic gene Bcl-2, effectively inhibiting the mitochondria-dependent cell death pathway. Morphological measurements also showed that the treatment group had larger seminiferous tubule diameters and a thicker germinal epithelium, indicating substantial repair of the damaged microenvironment.
The “Gap” from Bench to Bedside
Although the in vitro and animal experimental data are positive, there are still clear barriers before this technology can be truly applied in clinical practice. The study only tracked structural changes up to eight weeks after transplantation; it has not yet verified whether mature sperm capable of fertilization are produced, nor has it assessed transgenerational genetic safety. However, this does not undermine the possibility that adding chlorogenic acid to cryopreservation solutions may be a new strategy for addressing cryopreservation damage in tissues and organs.
Previous article
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.